Semin Neurol. 2004 Dec;24(4):395-404.

Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature.

Source

Department of Medical Oncology, Stanford University Medical Center, 300 Pasteur Drive, Palo Alto, CA 94305, USA.

Abstract

Direct invasion of the central nervous system (CNS) occurs in 5% of all patients with non-Hodgkin's lymphoma, either at the time of presentation, as a solitary site of relapse, or during the course of progressive disease. Over the last several years, several studies, mostly retrospective, have analyzed risk factors associated with this complication as well as various methods to both treat and prevent it. A systematic review of the literature reveals that although a profile of a patient at particularly high risk for developing disease can be identified, treatments are for the most part ineffective at improving survival in patients with CNS lymphoma, and there is no high-quality evidence that prophylaxis prevents its occurrence. A randomized controlled trial to assess the value of prophylaxis in this disease is warranted, and suggestions for how such a trial might be designed are included in this review.

PMID:: 15637651; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Lymphoma - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group. [Ann Oncol. 1998]
For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.
Bos GM, van Putten WL, van der Holt B, van den Bent M, Verdonck LF, Hagenbeek A. Ann Oncol. 1998 Feb; 9(2):191-4.
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. [Ann Oncol. 2002]
Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Ann Oncol. 2002 Jul; 13(7):1099-107.
Review To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma. [Curr Opin Oncol. 2008]
Review To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma.
Lim HY, Thiel E, Glantz MJ. Curr Opin Oncol. 2008 Sep; 20(5):495-501.
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). [Ann Oncol. 2007]
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N, German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Ann Oncol. 2007 Jan; 18(1):149-57. Epub 2006 Oct 3.
Review Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more. [Semin Oncol. 2009]
Review Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more.
Herrlinger U, Glantz M, Schlegel U, Gisselbrecht C, Cavalli F. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S25-34.

See reviews... See all...

Cited by 3 PubMed Central articles

Central nervous system relapses in 3 dogs with B-cell lymphoma. [Can Vet J. 2011]
Central nervous system relapses in 3 dogs with B-cell lymphoma.
Seo KW, Choi US, Lee JB, Kim MI, Oh YI, Chung JY, Lee SK, Hwang CY, Youn HY. Can Vet J. 2011 Jul; 52(7):778-83.
Review Central nervous system disease in hematologic malignancies: historical perspective and practical applications. [Semin Oncol. 2009]
Review Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH, Thiel E. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S2-S16.
Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases. [Neuro Oncol. 2006]
Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases.
Brandsma D, Ulfman L, Reijneveld JC, Bracke M, Taphoorn MJ, Zwaginga JJ, Gebbink MF, de Boer H, Koenderman L, Voest EE. Neuro Oncol. 2006 Apr; 8(2):127-36. Epub 2006 Mar 13.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prevention and treatment of central nervous system involvement by non-Hodgkin's ...
Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature.
Semin Neurol. 2004 Dec ;24(4):395-404.

PubMed
Assessing computational tools for the discovery of transcription factor binding ...
Assessing computational tools for the discovery of transcription factor binding sites.
Nat Biotechnol. 2005 Jan ;23(1):137-44.

PubMed
Is topical antifungal therapy effective in the treatment of chronic rhinosinusit...
Is topical antifungal therapy effective in the treatment of chronic rhinosinusitis?
J Allergy Clin Immunol. 2005 Jan ;115(1):123-4.

PubMed
A literature review of the effectiveness of ginger in alleviating mild-to-modera...
A literature review of the effectiveness of ginger in alleviating mild-to-moderate nausea and vomiting of pregnancy.
J Midwifery Womens Health. 2005 Jan-Feb ;50(1):e1-3.

PubMed
Lymphangioma of the kidney: a pathologic entity distinct from solitary multilocu...
Lymphangioma of the kidney: a pathologic entity distinct from solitary multilocular cyst.
Hum Pathol. 1992 Apr ;23(4):465-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: